This inventor holds 1 USPTO granted patent. Top assignee: Vita Genomics, Inc.. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Innovations by Shu-Ching Wang
Introduction
Shu-Ching Wang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical research, particularly in the treatment of hepatitis C virus (HCV) patients. His work focuses on improving treatment outcomes through innovative methodologies.
Latest Patents
Shu-Ching Wang holds a patent titled "Method for detecting a propensity of an individual to respond effectively to treatment of interferon-α and ribavirin combined therapy." This patent provides isolated polynucleotides that include sequences from the genomic region around the gene CD81. The polynucleotides encompass polymorphisms associated with treatment response in HCV patients to interferon-α and ribavirin combined therapy. They are useful as probes in screening for patients who will respond to this treatment. Additionally, the patent outlines the linkage disequilibrium structure of the CD81 gene and haplotype information within a specific LD block, which can be utilized for predicting treatment outcomes for HCV patients.
Career Highlights
Shu-Ching Wang is affiliated with Vita Genomics, Inc., where he continues to advance his research and innovations. His work has garnered attention for its potential to enhance the effectiveness of HCV treatments, thereby improving patient care.
Collaborations
Some of his notable coworkers include Kuang-Den Chen and Yuchi Hwang, who contribute to the collaborative efforts in research and development at Vita Genomics, Inc.
Conclusion
Shu-Ching Wang's innovative approaches in the field of medical research highlight the importance of personalized treatment strategies for HCV patients. His contributions through patents and collaborations continue to pave the way for advancements in healthcare.